Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted December 2, 2014
Glucosamine Class-Action Settlement Reversed by Appeals Court
For example, the proposed settlement would have allowed the companies to reword the claim "rebuilds cartilage" to "repairs cartilage" or "renews cartilage." It would also have allowed claims the Appeals Court called "dubious" - such as "maintain healthy connective tissue" and "improvements to joint discomfort in seven days" - to remain on the labels.
In addition, the Appeals Court estimated that only "one-fourth of one percent" of the estimated 12 million consumers who bought the products would receive "even modest compensation."
Glucosamine products affected by the lawsuit include Osteo-Biflex (Rexall Sundown) and generic versions sold by pharmacies such as CVS and Walgreens.
(See ConsumerLab.com's Review of Joint Health Supplements for tests of Osteo-Biflex and related products.)
The Appeals Court ordered the suit be sent back to trial court.
See Related Warnings:
To read the Appeals Court's full decision, use the link below.